We are live on ! Find out more
BHCM

Brevan Howard Capital Management Portfolio holdings

AUM $11.3B
1-Year Est. Return 35.84%
This Fund
S&P 500
This Quarter Est. Return
+6.05%
1 Year Est. Return
+35.84%
3 Year Est. Return
+106.49%
5 Year Est. Return
+80.14%
10 Year Est. Return
AUM
$9.16B
AUM Growth
-$13.2B
Cap. Flow
-$10.8B
Cap. Flow %
-117.92%
Top 10 Hldgs %
34.38%
Holding
2,371
New
451
Increased
532
Reduced
695
Closed
657

Sector Composition

Rank Sector Weight
1 Technology 8.09%
2 Financials 7.11%
3 Healthcare 5.24%
4 Communication Services 5.21%
5 Consumer Discretionary 4.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
REPX icon
1526
Riley Exploration Permian
REPX
$802M
$213K ﹤0.01%
+8,054
New +$214K
AAP icon
1527
Advance Auto Parts
AAP
$3.36B
$212K ﹤0.01%
5,395
-19,704
-79% -$988K
ROG icon
1528
Rogers Corp
ROG
$2.29B
$212K ﹤0.01%
+2,313
New +$199K
MATV icon
1529
Mativ Holdings
MATV
$706M
$211K ﹤0.01%
17,398
-3,449
-17% -$40.6K
PEB icon
1530
Pebblebrook Hotel Trust
PEB
$2B
$211K ﹤0.01%
+18,660
New +$205K
NBIX icon
1531
Neurocrine Biosciences
NBIX
$16.8B
$210K ﹤0.01%
1,481
-2,403
-62% -$348K
KR icon
1532
Kroger
KR
$34.6B
$210K ﹤0.01%
3,360
-14,286
-81% -$934K
LMRI
1533
Lumexa Imaging Holdings
LMRI
$1.13B
$210K ﹤0.01%
+11,340
New +$205K
UMBF icon
1534
UMB Financial
UMBF
$11.1B
$209K ﹤0.01%
+1,821
New +$206K
CRVL icon
1535
CorVel
CRVL
$3.12B
$209K ﹤0.01%
3,093
-297
-9% -$21.5K
GLUE icon
1536
Monte Rosa Therapeutics
GLUE
$1.35B
$209K ﹤0.01%
13,323
-33,589
-72% -$453K
MAZE
1537
Maze Therapeutics
MAZE
$1.51B
$209K ﹤0.01%
+5,042
New +$173K
CNI icon
1538
Canadian National Railway
CNI
$75.7B
$209K ﹤0.01%
+2,109
New +$203K
ASB icon
1539
Associated Banc-Corp
ASB
$5.92B
$208K ﹤0.01%
8,082
-29,620
-79% -$762K
ASM
1540
Avino Silver & Gold Mines
ASM
$1.28B
$208K ﹤0.01%
+33,495
New +$180K
ULCC icon
1541
Frontier Group Holdings
ULCC
$1.56B
$208K ﹤0.01%
+44,122
New +$195K
BMBL icon
1542
Bumble
BMBL
$360M
$208K ﹤0.01%
58,188
-108,081
-65% -$479K
NEE icon
1543
NextEra Energy
NEE
$177B
$208K ﹤0.01%
2,585
-19,698
-88% -$1.63M
INVX
1544
Innovex International
INVX
$2.04B
$207K ﹤0.01%
+9,472
New +$198K
NEO icon
1545
NeoGenomics
NEO
$2.14B
$207K ﹤0.01%
+17,575
New +$190K
AHRT
1546
AH Realty Trust
AHRT
$503M
$207K ﹤0.01%
31,217
+19,146
+159% +$126K
EXK
1547
Endeavour Silver
EXK
$3.03B
$206K ﹤0.01%
21,945
-47,337
-68% -$401K
NCNO icon
1548
nCino
NCNO
$2.08B
$206K ﹤0.01%
+8,044
New +$204K
KGS icon
1549
Kodiak Gas Services
KGS
$6.21B
$206K ﹤0.01%
5,498
-14,014
-72% -$496K
MVST icon
1550
Microvast
MVST
$291M
$205K ﹤0.01%
73,205
+60,317
+468% +$252K

Similar funds

Brevan Howard Capital Management's Q4 2025 Portfolio in Review

As of Q4 2025, Brevan Howard Capital Management held 2,371 positions worth $9.16B, down 59% from $22.4B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Brevan Howard Capital Management withdrew a net $10.8B in Q4 2025, closing 657 positions and reducing 695 holdings. Its most notable exit was Insmed, an estimated $42.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 8.1% of assets, up from 4.4% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Brevan Howard Capital Management opened a new position in First Trust Small Cap BuyWrite Income ETF worth $452M.

  • Brevan Howard Capital Management's largest Q4 2025 buy was First Trust Small Cap BuyWrite Income ETF: 57,081,120 shares worth $452M.
  • Brevan Howard Capital Management added most to Walmart Inc in Q4 2025, an estimated $84M increase.
  • Brevan Howard Capital Management's biggest Q4 2025 reduction was iShares Bitcoin Trust, cutting an estimated $1.77B.
  • Brevan Howard Capital Management fully exited Insmed in Q4 2025, selling an estimated $42.3M.
  • Brevan Howard Capital Management's ten largest holdings make up 34% of its $9.16B portfolio in Q4 2025.
  • Brevan Howard Capital Management opened 451 new positions and closed 657 in Q4 2025.
  • Brevan Howard Capital Management's portfolio value fell 59% quarter-over-quarter to $9.16B.

Based on Brevan Howard Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.